Clinical trials
Leukemia trials in Belgium with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 11 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Antisoma Research | 1 |
| Commissie Voor Klinisch Toegepast Onderzoek | 1 |
| Dutch Childhood Oncology Group | 1 |
| European Working Group of MDS in Childhood | 1 |
| Facet Biotech | 1 |
| Glycostem Therapeutics BV | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| University Medical Center Groningen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 21 |
| Leukemia, Myeloid, Acute | 8 |
| Leukemia, Erythroblastic, Acute | 5 |
| Leukemia, Megakaryoblastic, Acute | 5 |
| Leukemia, Monocytic, Acute | 5 |
| Leukemia, Myelomonocytic, Acute | 5 |
| Myelodysplastic Syndromes | 5 |
| Lymphoma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia, Refractory | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.